Public releases


2020 third quarter consolidated sales

2020/10/14 - Financial public releases

Revenue grew +6.8% at constant exchange rates and scope at the end of September 2020 (+5.6% at constant rates) thanks to solid third quarter performance

Read more

Virbac governance evolution

2020/10/13 - Financial public releases

Virbac will change its governance at its shareholders' meeting on December 15

Read more

2020 half year results

2020/09/16 - Financial public releases

Operating profit from ordinary activities up sharply for the first half of 2020 reflecting revenue resiliency and strong expenditure restraint during the Covid-19 crisis

Read more

2020 second quarter consolidated sales

2020/07/20 - Financial public releases

Revenue grew by +5.0% at constant exchange rates in the first half of 2020 (+4.5% excluding Sentinel), impacted by a decline in the second quarter of the year

Read more

Divestment of US rights

2020/07/02 - Financial public releases

Virbac completes divestment of U.S. Rights to SENTINEL® brands to MSD Animal Health

Read more

Signing of an agreement

2020/05/13 - Financial public releases

Virbac to divest U.S. Rights to SENTINEL® brands to MSD Animal Health

Read more

2020 first quarter consolidated sales

2020/04/15 - Financial public releases

2020 first quarter revenue rose by +14.3% at comparable exchange rates, significantly impacted by anticipatory buying

Read more